Forward Pharma A/S Discounted Cash Flow

As of the most recent data, FWP shows a DCF fair value of $12. Scroll down for historical charts and peer comparison views.

Forward Pharma A/S's DCF reading of $12 (519.7% undervalued) is a model output, not a certainty. Small changes in long-term growth or the discount rate can move fair value a lot. Treat the number as a structured starting point, then verify whether Forward Pharma A/S's recent cash-flow history supports the assumptions.

Besides this discounted cash flow page, Stockcircle has Forward Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect DCF fair value (currently $12) with ownership activity and broader fundamentals.

Forward Pharma A/S's DCF fair value is $12; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.